130 related articles for article (PubMed ID: 22529624)
1. Enterococcal Bacteremia is Associated with Prolonged Stay in the Medical Intensive Care Unit.
Moses V; Jerobin J; Nair A; Sathyendara S; Balaji V; George IA; Peter JV
J Glob Infect Dis; 2012 Jan; 4(1):26-30. PubMed ID: 22529624
[TBL] [Abstract][Full Text] [Related]
2. Enterococcal bacteremia in the surgical intensive care unit. Does vancomycin resistance affect mortality? The Johns Hopkins SICU Study Group.
Mainous MR; Lipsett PA; O'Brien M
Arch Surg; 1997 Jan; 132(1):76-81. PubMed ID: 9006556
[TBL] [Abstract][Full Text] [Related]
3. Measuring Epidemiologic Effects of Enterococcal Bacteremia and Outcomes From a Nationwide Inpatient Sample Database.
Cheriyath P; Prasad A; Patel P; Vankeshwaram V; Seeburun S; Ghodasara K; Pavuluri S
Cureus; 2022 Jul; 14(7):e27516. PubMed ID: 36060337
[TBL] [Abstract][Full Text] [Related]
4. Epidemiology, Management, and Risk-Adjusted Mortality of ICU-Acquired Enterococcal Bacteremia.
Ong DS; Bonten MJ; Safdari K; Spitoni C; Frencken JF; Witteveen E; Horn J; Klein Klouwenberg PM; Cremer OL;
Clin Infect Dis; 2015 Nov; 61(9):1413-20. PubMed ID: 26179013
[TBL] [Abstract][Full Text] [Related]
5. Vancomycin-resistant enterococcal bacteremia: comparison of clinical features and outcome between Enterococcus faecium and Enterococcus faecalis.
Chou YY; Lin TY; Lin JC; Wang NC; Peng MY; Chang FY
J Microbiol Immunol Infect; 2008 Apr; 41(2):124-9. PubMed ID: 18473099
[TBL] [Abstract][Full Text] [Related]
6. Enterococcal bacteraemia: factors influencing mortality, length of stay and costs of hospitalization.
Cheah AL; Spelman T; Liew D; Peel T; Howden BP; Spelman D; Grayson ML; Nation RL; Kong DC
Clin Microbiol Infect; 2013 Apr; 19(4):E181-9. PubMed ID: 23398607
[TBL] [Abstract][Full Text] [Related]
7. Enterococcal bacteremia in a tertiary care centre in Winnipeg.
Madani TA; Kabani A; Orr P; Nicolle L
Can J Infect Dis; 1999 Jan; 10(1):57-63. PubMed ID: 22346373
[TBL] [Abstract][Full Text] [Related]
8. The incidence of and clinical variables associated with vancomycin-resistant enterococcal colonization in mechanically ventilated patients.
Bhorade SM; Christenson J; Pohlman AS; Arnow PM; Hall JB
Chest; 1999 Apr; 115(4):1085-91. PubMed ID: 10208212
[TBL] [Abstract][Full Text] [Related]
9. Neonatal enterococcal bacteremia: an increasingly frequent event with potentially untreatable pathogens.
McNeeley DF; Saint-Louis F; Noel GJ
Pediatr Infect Dis J; 1996 Sep; 15(9):800-5. PubMed ID: 8878225
[TBL] [Abstract][Full Text] [Related]
10. Enterococcal bacteremia in a medical center.
Peng MY; Young TG; Yang CH; Chou MY
Zhonghua Yi Xue Za Zhi (Taipei); 1994 Nov; 54(5):306-11. PubMed ID: 7834553
[TBL] [Abstract][Full Text] [Related]
11. Clinical features of enterococcal bacteremia due to ampicillin-susceptible and ampicillin-resistant enterococci: An eight-year retrospective comparison study.
Hamada Y; Magarifuchi H; Oho M; Kusaba K; Nagasawa Z; Fukuoka M; Yamakuchi H; Urakami T; Aoki Y
J Infect Chemother; 2015 Jul; 21(7):527-30. PubMed ID: 25935477
[TBL] [Abstract][Full Text] [Related]
12. Risk Factors for Enterococcal Intra-Abdominal Infections and Outcomes in Intensive Care Unit Patients.
Luo X; Li L; Xuan J; Zeng Z; Zhao H; Cai S; Huang Q; Guo X; Chen Z
Surg Infect (Larchmt); 2021 Oct; 22(8):845-853. PubMed ID: 33769911
[No Abstract] [Full Text] [Related]
13. A 25-year study of nosocomial bacteremia in an adult intensive care unit.
Edgeworth JD; Treacher DF; Eykyn SJ
Crit Care Med; 1999 Aug; 27(8):1421-8. PubMed ID: 10470744
[TBL] [Abstract][Full Text] [Related]
14. Continuous increase of vancomycin resistance in enterococci causing nosocomial infections in Germany - 10 years of surveillance.
Remschmidt C; Schröder C; Behnke M; Gastmeier P; Geffers C; Kramer TS
Antimicrob Resist Infect Control; 2018; 7():54. PubMed ID: 29760912
[TBL] [Abstract][Full Text] [Related]
15. Genetic relatedness and risk factor analysis of ampicillin-resistant and high-level gentamicin-resistant enterococci causing bloodstream infections in Tanzanian children.
Aamodt H; Mohn SC; Maselle S; Manji KP; Willems R; Jureen R; Langeland N; Blomberg B
BMC Infect Dis; 2015 Feb; 15():107. PubMed ID: 25884316
[TBL] [Abstract][Full Text] [Related]
16. Effect of nosocomial vancomycin-resistant enterococcal bacteremia on mortality, length of stay, and costs.
Song X; Srinivasan A; Plaut D; Perl TM
Infect Control Hosp Epidemiol; 2003 Apr; 24(4):251-6. PubMed ID: 12725353
[TBL] [Abstract][Full Text] [Related]
17. Measurement of ampicillin, vancomycin, linezolid and gentamicin activity against enterococcal biofilms.
Sandoe JA; Wysome J; West AP; Heritage J; Wilcox MH
J Antimicrob Chemother; 2006 Apr; 57(4):767-70. PubMed ID: 16464896
[TBL] [Abstract][Full Text] [Related]
18. Nosocomial infections in combined medical-surgical intensive care units in the United States.
Richards MJ; Edwards JR; Culver DH; Gaynes RP
Infect Control Hosp Epidemiol; 2000 Aug; 21(8):510-5. PubMed ID: 10968716
[TBL] [Abstract][Full Text] [Related]
19. Determinants of vancomycin resistance and mortality rates in enterococcal bacteremia. a prospective multicenter study.
Vergis EN; Hayden MK; Chow JW; Snydman DR; Zervos MJ; Linden PK; Wagener MM; Schmitt B; Muder RR
Ann Intern Med; 2001 Oct; 135(7):484-92. PubMed ID: 11578151
[TBL] [Abstract][Full Text] [Related]
20. Enterococcal bacteremia: clinical features, the risk of endocarditis, and management.
Maki DG; Agger WA
Medicine (Baltimore); 1988 Jul; 67(4):248-69. PubMed ID: 3134590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
